Patients, pharma push docs to prescribe brand-name drugs

Patients and pharma companies are both adept at twisting physicians' arms toward branded drugs, according to a new study from researchers from the Harvard Medical School and Massachusetts General Hospital, published in this week's JAMA Internal Medicine. The researchers surveyed 3,500 doctors in seven specialties and found that about 40 percent of physicians sometimes or often prescribe a brand-name drug rather than a generic one when a patient asks for the brand. That statistic suggests that drugmakers' multibillion-dollar investment in direct-to-consumer advertising pays off. --Read the full story from FiercePharma

Suggested Articles

While it continues to oppose “Medicare for All,” the American Medical Association has dropped out of a coalition organized to fight the proposal.

Experts who examined 21 California cases in which extreme risk protection orders were used suggest they can play a role in preventing mass shootings.

The opioid epidemic prompted some medical centers and groups of physicians to establish surgery-specific prescribing guidelines. How have they worked?